scholarly journals The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis

HPB ◽  
2016 ◽  
Vol 18 ◽  
pp. e756
Author(s):  
S. Paiella ◽  
M. Sandini ◽  
L. Gianotti ◽  
R. Salvia ◽  
C. Bassi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pancreatic Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Meta Analysis ◽  
Prognostic Impact ◽  
Node Metastasis ◽  
Aortic Lymph Node

scholarly journals Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer

2021 ◽  
Vol 28 (3) ◽  
pp. 1663-1672
Author(s):  
Satomi Hattori ◽  
Nobuhisa Yoshikawa ◽  
Kazumasa Mogi ◽  
Kosuke Yoshida ◽  
Masato Yoshihara ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Tumor Size ◽  
Concurrent Chemoradiotherapy ◽  
Primary Treatment ◽  
Prognostic Impact ◽  
Primary Tumor Size ◽  
Node Metastasis ◽  
Aortic Lymph Node

(1) This study investigated the prognostic impact of tumor size in patients with metastatic cervical cancer. (2) Methods: Seventy-three cervical cancer patients in our institute were stratified into two groups based on distant metastasis: para-aortic lymph node metastasis alone (IIIC2) or spread to distant visceral organs with or without para-aortic lymph node metastasis (IVB) to identify primary tumor size and concurrent chemoradiotherapy. (3) Results: The overall survival (OS) for patients with a tumor >6.9 cm in size was significantly poorer than that for patients with a tumor ≤6.9 cm in the IVB group (p = 0.0028); the corresponding five-year OS rates in patients with a tumor ≤6.9 and >6.9 cm were 53.3% and 13.4%, respectively. In the multivariate analysis, tumor size and primary treatment were significantly associated with survival in metastatic cervical cancer. (4) Conclusions: Tumor size ≤6.9 cm and concurrent chemoradiotherapy as the primary treatment were favorable prognostic factors for patients with metastatic cervical cancer.

CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis

2018 ◽  
Vol 17 (1) ◽  
pp. 75-80
Author(s):  
Tadafumi Asaoka ◽  
Atsushi Miyamoto ◽  
Sakae Maeda ◽  
Naoki Hama ◽  
Masanori Tsujie ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Therapeutic Modality ◽  
Node Metastasis ◽  
Aortic Lymph Node
Sign in / Sign up

Export Citation Format

Share Document